Founded in 2020, BrainQUANT brings together molecular profiling, cellular and spatial mapping, experimental models, and human neuroimaging to understand the brain across scales: from molecules and cells to circuits and patients. Our goal is to identify the mechanisms, biomarkers, and therapeutic targets that can enable more precise approaches to psychiatric and neurological disease.